Inventor
LIRAS SPIROS
US17 patents
⚠️ This page may combine multiple inventors who share the name “LIRAS SPIROS”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
PFIZER
15 patentsUS6720336B2Apr 13, 2004
4,4-biarylpiperidine derivatives
PFIZER47 citations92
US9617293B2Apr 11, 2017
Substituted-6,8-dioxabicyclo[3.2.1]octane-2,3-diol compounds as targeting agents of ASGPR
PFIZER15 citations91
US7049335B2May 23, 2006
3-azabicyclo[3.1.0]hexane derivatives
PFIZER40 citations89
US10813942B2Oct 27, 2020
Substituted-6,8-dioxabicyclo[3.2.1]octane-2,3-diol compounds as targeting agents of ASGPR
PFIZER7 citations83
US10376531B2Aug 13, 2019
Substituted-6,8-dioxabicyclo[3.2.1]octane-2,3-diol compounds as targeting agents of ASGPR
PFIZER8 citations83
US10039778B2Aug 7, 2018
Substituted-6,8-dioxabicyclo[3.2.1]octane-2,3-diol compounds as targeting agents of ASGPR
PFIZER11 citations83
US9340553B2May 17, 2016
Substituted-6,8-dioxabicyclo[3.2.1]octane-2,3-diol compounds as targeting agents of ASGPR
PFIZER12 citations83
US7238721B2Jul 3, 2007
Pyrazole compounds for treatment of neurodegenerative disorders
PFIZER13 citations83
US7268142B2Sep 11, 2007
Tetrahydroisoquinolinyl derivatives of quinazoline and isoquinoline
PFIZER16 citations80
US7521464B2Apr 21, 2009
Pyrazole compounds for treatment of neurodegenerative disorders
PFIZER7 citations72
US6444679B1Sep 3, 2002
4-phenyl-4-heteroarylpiperidine derivatives
PFIZER8 citations72
US6503905B1Jan 7, 2003
3,3-biarylpiperidine and 2,2-biarylmorpholine derivatives
PFIZER6 citations70
US7456177B2Nov 25, 2008
Heteroaryl fused azapolycyclic compounds
PFIZER2 citations61
US6586431B1Jul 1, 2003
3,3-Biarylpiperidine and 2,2-biarylmorpholine derivatives
PFIZER4 citations59
US10851367B2Dec 1, 2020
Tissue-specific genome engineering using CRISPR-Cas9
PFIZER1 citations56